The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Effects of Diet versus Gastric Bypass on Metabolic Function in Diabetes
Open accessAbstract
BACKGROUND: Some studies have suggested that in people with type 2 diabetes, Roux-en-Y gastric bypass has therapeutic effects on metabolic function that are independent of weight loss. METHODS: We evaluated metabolic regulators of glucose homeostasis before and after matched (approximately 18%) weight loss induced by gastric bypass (surgery group) or diet alone (diet group) in 22 patients with obesity and diabetes. The primary outcome was the change in hepatic insulin sensitivity, assessed by infusion of insulin at low rates (stages 1 and 2 of a 3-stage hyperinsulinemic euglycemic pancreatic clamp). Secondary outcomes were changes in muscle insulin sensitivity, beta-cell function, and 24-hour plasma glucose and insulin profiles. RESULTS: Weight loss was associated with increases in mean suppression of glucose production from baseline, by 7.04 μmol per kilogram of fat-free mass per minute (95% confidence interval [CI], 4.74 to 9.33) in the diet group and by 7.02 μmol per kilogram of fat-free mass per minute (95% CI, 3.21 to 10.84) in the surgery group during clamp stage 1, and by 5.39 (95% CI, 2.44 to 8.34) and 5.37 (95% CI, 2.41 to 8.33) μmol per kilogram of fat-free mass per minute in the two groups, respectively, during clamp stage 2; there were no significant differences between the groups. Weight loss was associated with increased insulin-stimulated glucose disposal, from 30.5±15.9 to 61.6±13.0 μmol per kilogram of fat-free mass per minute in the diet group and from 29.4±12.6 to 54.5±10.4 μmol per kilogram of fat-free mass per minute in the surgery group; there was no significant difference between the groups. Weight loss increased beta-cell function (insulin secretion relative to insulin sensitivity) by 1.83 units (95% CI, 1.22 to 2.44) in the diet group and by 1.11 units (95% CI, 0.08 to 2.15) in the surgery group, with no significant difference between the groups, and it decreased the areas under the curve for 24-hour plasma glucose and insulin levels in both groups, with no significant difference between the groups. No major complications occurred in either group. CONCLUSIONS: In this study involving patients with obesity and type 2 diabetes, the metabolic benefits of gastric bypass surgery and diet were similar and were apparently related to weight loss itself, with no evident clinically important effects independent of weight loss. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT02207777.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Caloric restriction can rapidly reduce steatosis and hepatic insulin resistance [41][42][43].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with type 2 diabetes, weight loss after bariatric surgery elicited no additional differences in hepatic or whole-body insulin sensitivity compared to a control diet with comparable calorie intake, suggesting that the reduction of body fat mass is the major contributing factor to the observed metabolic benefits [43].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent interventions with intensive diet and exercise, newer pharmacological agents (e.g., glucagon-like peptide 1 receptor agonists), or surgical weight loss have led to diabetes remission (86 -92)”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [91]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742
Self-citationBokulich, N. A., Kaehler, B. D., Rideout, J. R., Dillon, M. R., Bolyen, E. K., Knight, R. D., Huttley, G. A., & Caporaso, J. G. (2018) · Microbiome · doi:10.1186/s40168-018-0470-z · Cited by 6,037
Self-citationMechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401329 · Cited by 1,901
Human gut microbiota in obesity and after gastric bypass
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., Parameswaran, P., Crowell, M. D., Wing, R., Rittmann, B. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812600106 · Cited by 1,880
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss
Furet, J.-P., Kong, L.-C., Tap, J., Poitou, C., Basdevant, A., Bouillot, J.-L., Mariat, D., Corthier, G., Doré, J., Henegar, C., et al. (2010) · Diabetes · doi:10.2337/db10-0253 · Cited by 1,173
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Cited by
Sorted by citations
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s002 · Cited by 3,116
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D. M., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,841
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
Sarma, S., Sockalingam, S., & Dash, S. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14290 · Cited by 485
Reassessing human adipose tissue
Cypess, A. M. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2032804 · Cited by 404
The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia
Sylow, L., Tokarz, V. L., Richter, E. A., & Klip, A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.020 · Cited by 366
Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
van Veldhuisen, S. L., Gorter, T. M., van Woerden, G., de Boer, R. A., Rienstra, M., Hazebroek, E. J., & van Veldhuisen, D. J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac071 · Cited by 322
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 232
Lima, J. E. B. F., Moreira, N. C. S., & Sakamoto-Hojo, E. T. (2022) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2021.503437 · Cited by 203
Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia
Sandoval, D. A., & Patti, M. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00757-5 · Cited by 218
Linge, J., Birkenfeld, A. L., & Neeland, I. J. (2024) · Circulation · doi:10.1161/circulationaha.124.067676 · Cited by 180
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155937 · Cited by 169
Factors affecting weight loss variability in obesity
Dent, R., McPherson, R., & Harper, M.-E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154388 · Cited by 131
Koutoukidis, D. A., Jebb, S. A., Zimmerman, M., Otunla, A. A., Henry, J. A., Ferrey, A. E., Schofield, E., Kinton, J., Aveyard, P. N., & Marchesi, J. R. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2020068 · Cited by 123
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases
Fontana, L., Ghezzi, L., Cross, A. H., & Piccio, L. M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190086 · Cited by 119
Long-term effectiveness, outcomes and complications of bariatric surgery
Gulinac, M., Miteva, D., Peshevska-Sekulovska, M., Novakov, I. P., Antović, S., Peruhova, M., Snegarova, V., Kabakchieva, P., Assyov, Y. S., Vasilev, G., et al. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i19.4504 · Cited by 115
Inflammatory and fibrotic mechanisms in NAFLD—Implications for new treatment strategies
Lee, Y. A., & Friedman, S. L. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13380 · Cited by 104
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review
Dandona, P., Dhindsa, S., Ghanim, H., & Saad, F. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14206 · Cited by 90
Understanding the cause of type 2 diabetes
Taylor, R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00157-8 · Cited by 88
Regulation of body weight: Lessons learned from bariatric surgery
Albaugh, V. L., He, Y., Münzberg, H., Morrison, C. D., Yu, S., & Berthoud, H. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101517 · Cited by 80
Shin, J. H., Bozadjieva-Kramer, N., Shao, Y., Lyons‐Abbott, S., Rupp, A. C., Sandoval, D. A., & Seeley, R. J. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.024 · Cited by 80
The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings
Tucker, S., Bramante, C. T., Conroy, M. B., Fitch, A., Gilden, A. H., Wittleder, S., & Jay, M. R. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00444-y · Cited by 76
Rosenfeld, R. M., Kelly, J. H., Agarwal, M., Aspry, K., Barnett, T., Davis, B. C., Fields, D., Gaillard, T., Gulati, M., Guthrie, G. E., et al. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087624 · Cited by 71
Park, J., Ntelis, S., Yunasan, E., Downton, K. D., Yip, T. C.-F., Munir, K. M., & Haq, N. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad471 · Cited by 69
Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
Papamargaritis, D., & le Roux, C. W. (2021) · Nutrients · doi:10.3390/nu13030762 · Cited by 68
Prevention of cardiorenal complications in people with type 2 diabetes and obesity
Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.018 · Cited by 68
Raverdy, V., COHEN, R. V., Caiazzo, R. J., Verkindt, H., Petry, T. B. Z., Marciniak, C., Legendre, B. L., Bauvin, P., Chatelain, E., Duhamel, A., et al. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00005-5 · Cited by 67
Purnell, J. Q., Dewey, E. N., Laferrère, B., Selzer, F., Flum, D. R., Mitchell, J. E., Pomp, A., Pories, W. J., Inge, T. H., Courcoulas, A. P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa849 · Cited by 71
Murphy, R., Plank, L. D., Clarke, M., Evennett, N. J., Tan, J., Kim, D. D. W., Cutfield, R. G., & Booth, M. (2022) · Diabetes Care · doi:10.2337/dc21-2498 · Cited by 75
Simancas-Racines, D., Annunziata, G., Verde, L., Fascì-Spurio, F., Reytor-González, C., Muscogiuri, G., Frias-Toral, E., & Barrea, L. (2025) · Current Obesity Reports · doi:10.1007/s13679-024-00597-6 · Cited by 61
Obesity and Cardiovascular Disease: The Emerging Role of Inflammation
Khafagy, R. T. M., & Dash, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.768119 · Cited by 69
Hepatic glucagon action: beyond glucose mobilization
Kajani, S., Laker, R. C., Ratkova, E. L., Will, S., & Rhodes, C. J. (2024) · Physiological Reviews · doi:10.1152/physrev.00028.2023 · Cited by 65
Ferguson, D., Eichler, S. J., Yiew, N. K. H., Colca, J. R., Cho, K., Patti, G. J., Shew, T. M., Lutkewitte, A. J., Mukherjee, S. K., McCommis, K. S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101694 · Cited by 55
Mucinski, J. M., Salvador, A. F., Moore, M. P., Fordham, T. M., Anderson, J. M., Shryack, G. E., Cunningham, R. P., Lastra, G., Gaballah, A. H., Diaz‐Arias, A. A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.017 · Cited by 58
Minimum Threshold of Bariatric Surgical Weight Loss for Initial Diabetes Remission
Barthold, D., Brouwer, E., Barton, L. J., Arterburn, D. E., Basu, A., Courcoulas, A. P., Crawford, C. L., Fedorka, P. N., Fischer, H. J., Kim, B. B., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0714 · Cited by 53
Awuchi, C. G., & Okpala, C. O. R. (2022) · Journal of Food Bioactives · doi:10.31665/jfb.2022.18317 · Cited by 59
Bile acid metabolism in type 2 diabetes mellitus
Sandoval, M. C., & Haeusler, R. A. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01067-8 · Cited by 54
Precision nutrition in diabetes: when population-based dietary advice gets personal
Merino, J. (2022) · Diabetologia · doi:10.1007/s00125-022-05721-6 · Cited by 53
Potential gut–brain mechanisms behind adverse mental health outcomes of bariatric surgery
Brown, R. M., Guerrero-Hreins, E., Brown, W. A., le Roux, C. W., & Sumithran, P. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00520-2 · Cited by 49
Ding, L., Zhang, E., Yang, Q., Jin, L., Sousa, K. M., Dong, B., Wang, Y., Tu, J., Ma, X., Tian, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019388118 · Cited by 47
Metabolic surgery: A clinical update
Wilson, R. L., Aminian, A., & Tahrani, A. A. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14235 · Cited by 42
The Impact of the Rate of Weight Loss on Body Composition and Metabolism
Fogarasi, A., Gonzalez, K. D., Dalamaga, Μ., & Magkos, F. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00470-4 · Cited by 41
Insulin Clearance in Obesity and Type 2 Diabetes
Koh, H. E., Cao, C., & Mittendorfer, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020596 · Cited by 52
Sbraccia, P., D’Adamo, M., & Guglielmi, V. (2021) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-021-01109-4 · Cited by 43
Al-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 43
Wahlstrom, A. M., Aydin, Ö., Olsson, L. M., Sjöland, W., Henricsson, M., Lundqvist, A., Marschall, H., Franken, R. J., van de Laar, A. W. J. M., Gerdes, V. E. A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105265 · Cited by 37
Continued Diabetes Remission Despite Weight Recurrence: Gastric Bypass Long-Term Metabolic Benefit
Ghanem, O. M., Mosleh, K. A., Kerbage, A., Lu, L. Y., Hage, K., & Dayyeh, B. K. A. (2024) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000934 · Cited by 35
Hoozemans, J., de Brauw, M., Nieuwdorp, M., & Gerdes, V. E. A. (2021) · Metabolites · doi:10.3390/metabo11060353 · Cited by 36
Halpern, B., Mancini, M. C., de Melo, M. E., Lamounier, R. N., Moreira, R. O., Carra, M. K., Kyle, T. K., Cercato, C., & Boguszewski, C. L. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000465 · Cited by 41
Brzozowska, M. M., Isaacs, M., Bliuc, D., Baldock, P. A. J., Eisman, J. A., White, C., & Greenfield, J. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33317-6 · Cited by 38
Dreyfuss, J. M., Yuchi, Y., Dong, X., Efthymiou, V., Pan, H., Simonson, D. C., Vernon, A. H., Halperin, F., Aryal, P., Konkar, A. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27289-2 · Cited by 36
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes Care · doi:10.2337/dci21-0051 · Cited by 36
Decreased Weight Loss Following Bariatric Surgery in Patients with Type 2 Diabetes
Rebelos, E., Moriconi, D., Honka, M., Anselmino, M., & Nannipieri, M. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06350-z · Cited by 34
Bakbak, E., Terenzi, D. C., Trac, J. Z., Teoh, H., Quan, A., Glazer, S. A., Rotstein, O. D., Al-Omran, M. A., Verma, S., & Hess, D. A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09669-7 · Cited by 32
Zhu, J., Han, J., Liu, L., Liu, Y., Xu, W., Li, X., Yang, L., Gu, Y., Tang, W., Shi, Y., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110568 · Cited by 31
Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery
Cordido, M., Juiz-Valiña, P., Urones, P., Sangiao‐Alvarellos, S., & Cordido, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051340 · Cited by 29
Schyr, R. B., Al‐Kurd, A., Moalem, B., Permyakova, A., Israeli, H., Bardugo, A., Arad, Y., Hefetz, L., Bergel, M., Haran, A., et al. (2021) · Diabetes · doi:10.2337/db21-0251 · Cited by 26
Managing dyslipidemia in patients with Type 2 diabetes
Tomlinson, B., Patil, N. G., Fok, M., & Lam, C. W. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1912734 · Cited by 25
Human White Adipose Tissue Displays Selective Insulin Resistance in the Obese State
Mileti, E., Kwok, K. H. M., Andersson, D. P., Mathelier, A., Raman, A., Bäckdahl, J., Jalkanen, J., Massier, L., Thorell, A., Gao, H., et al. (2021) · Diabetes · doi:10.2337/db21-0001 · Cited by 27
Wu, H., Yang, A., Lau, E. S. H., Zhang, X., Fan, B., Ma, R. C. W., Kong, A. P. S., Chow, E., So, W.-Y., Chan, J. C. N., et al. (2024) · PLOS Medicine · doi:10.1371/journal.pmed.1004327 · Cited by 24
Salehi, M., Gastaldelli, A., & DeFronzo, R. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155199 · Cited by 21
Yoshino, M., Yoshino, J., Smith, G. I., Stein, R. I., Bittel, A. J., Bittel, D. C., Reeds, D. N., Sinacore, D. R., Cade, W. T., Patterson, B. W., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.08.012 · Cited by 26
Self-citationEffect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes
Samovski, D., Smith, G. I., Palacios, H. H., Pietka, T., Fuchs, A. G., Patti, G. J., Nawaz, A., Kahn, C. R., & Klein, S. (2025) · Diabetes Care · doi:10.2337/dc24-2739 · Cited by 23
Self-citationHamaya, R., Mora, S., Lawler, P. R., Cook, N. R., Buring, J. E., Lee, I.-M. M., Manson, J. E., & Tobias, D. K. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac056 · Cited by 23
The Beneficial Effects of Bariatric-Surgery-Induced Weight Loss on Renal Function
Moriconi, D., Nannipieri, M., Dadson, P., Rosada, J., Tentolouris, N., & Rebelos, E. (2022) · Metabolites · doi:10.3390/metabo12100967 · Cited by 22
Could Naringenin Participate as a Regulator of Obesity and Satiety?
López-Almada, G., Domínguez-Avila, J. A., Mejía-León, M. E., Robles‐Sánchez, M., González-Aguilar, G. A., & Salazar‐López, N. J. (2023) · Molecules · doi:10.3390/molecules28031450 · Cited by 22
Effect of Weight Loss on Skeletal Muscle Bioactive Lipids in People With Obesity and Type 2 Diabetes
Petersen, M. C., Yoshino, M., Smith, G. I., Gaspar, R. C., Kahn, M., Samovski, D., Shulman, G. I., & Klein, S. (2024) · Diabetes · doi:10.2337/db24-0083 · Cited by 21
Self-citationGow, M. L., Pham-Short, A., Jebeile, H., Varley, B. J., & Craig, M. E. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s238419 · Cited by 21
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., & Rosenblum, N. D. (2021) · Diabetes · doi:10.2337/db21-0777 · Cited by 20
Salehi, M., DeFronzo, R. A., & Gastaldelli, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147667 · Cited by 18
Dumping Syndrome and Postbariatric Hypoglycemia: Supporting Evidence for a Common Etiology
van Furth, A. M., de Heide, L. J. M., Emous, M., Veeger, N. J. G. M., & van Beek, A. P. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.05.020 · Cited by 26
PRASAD, M. A., Mark, V., Ligon, C., Dutia, R., Nair, N., Shah, A. M., & Laferrère, B. (2021) · Diabetes Care · doi:10.2337/dc21-1270 · Cited by 19
Magkos, F., Reeds, D. N., & Mittendorfer, B. (2022) · Physiological Reviews · doi:10.1152/physrev.00015.2022 · Cited by 20
Self-citationEffects of whole grain intake on glycemic control: A meta‐analysis of randomized controlled trials
Li, Z., Yan, H., Chen, L., Wang, Y., Liang, J., Feng, X., Hui, S., & Wang, K. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13866 · Cited by 17
Plaeke, P., Beunis, A., Ruppert, M., Man, J. G. D., Winter, B. Y. D., & Hubens, G. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05157-0 · Cited by 19
Kirwan, J. P., Axelrod, C. L., Kullman, E. L., Malin, S. K., Dantas, W. S., Belmont, K. P., del Rincon, J. P., Brethauer, S. A., Kashyap, S. R., & Schauer, P. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab255 · Cited by 15
Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?
Laurila, S., Rebelos, E., Honka, M., & Nuutila, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.737686 · Cited by 16
Contemporary Clinical Perspectives on Targeting Remission of Type 2 Diabetes
Retnakaran, R. R., Kashyap, S. R., Gerstein, H. C., & Aroda, V. R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad746 · Cited by 17
Axelrod, C. L., Hari, A., Dantas, W. S., Kashyap, S. R., Schauer, P. R., & Kirwan, J. P. (2024) · Diabetes Care · doi:10.2337/dc24-0859 · Cited by 17
Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
Finan, B., Parlee, S. D., & Yang, B. S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101153 · Cited by 16
Sandby, K., Geiker, N. R. W., Dalamaga, Μ., Grønbæk, H., & Magkos, F. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00430-4 · Cited by 16
Bariatric Surgery and Restoration of Insulin Sensitivity — It’s Weight Loss
Rosen, C. J., & Ingelfinger, J. R. (2020) · New England Journal of Medicine · doi:10.1056/nejme2024212 · Cited by 16
Zhao, Z., Liu, S., Qian, B., Zhou, L., Shi, J., Liu, J., Xu, L., & Yang, Z. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.06.014 · Cited by 15
Mosinski, J. D., Aminian, A., Axelrod, C. L., Batayyah, E., Romero‐Talamás, H., Daigle, C. R., Mulya, A., Scelsi, A. R., Schauer, P. R., Brethauer, S. A., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00467.2020 · Cited by 15
Weighing in on Type 2 Diabetes Remission
Meerasa, A., & Dash, S. (2021) · Diabetes Care · doi:10.2337/dci21-0041 · Cited by 17
Bouchard‐Mercier, A., de Toro‐Martín, J., Nadeau, M., Lescelleur, O., Lebel, S., Richard, D., Biertho, L. D., Tchernof, A., & Vohl, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03485-6 · Cited by 15
Giuseppe, G. D., Ciccarelli, G., CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Capece, U., Pontecorvi, A., Giaccari, A., & Mezza, T. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03405-9 · Cited by 17
Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
Sasaki, H., Saisho, Y., Inaishi, J., & Itoh, H. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab128 · Cited by 16
The dual impact: physiological and psychological effects of rapid weight loss in wrestling
Sarıakçalı, B., Şahin, F. N., Başoğlu, B., Ceylan, L., Güler, Ö., Yamak, B., Arıkan, G., Ceylan, G., Sekban, G., DURMUŞOĞLU, M. V., et al. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1513129 · Cited by 13
Orioli, L., & Thissen, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554617 · Cited by 17
Epigenetic Signatures in Arterial Hypertension: Focus on the Microvasculature
Mengozzi, A., Costantino, S., Mongelli, A., Mohammed, S. A., Gorica, E., Delfine, V., Masi, S., Virdis, A., Ruschitzka, F. T., & Paneni, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054854 · Cited by 13
Novel aspects on the role of white adipose tissue in type 2 diabetes
Mejhert, N., & Rydén, M. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.09.008 · Cited by 13
The effect of bariatric surgery on ischemic stroke risk
Williams, M. D., Kim, S., Sarran, M., Khalid, S. I., Becerra, A. Z., Torquati, A., & Omotosho, P. A. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.09.006 · Cited by 12
Remission of type 2 diabetes: A critical appraisal
Ricci, M., Mancebo-Sevilla, J. J., Cobos-Palacios, L., Sanz‐Cánovas, J., Sampalo, A. L., Hernández-Negrín, H., Velasco, M. Á. P., Perez-Belmonte, L. M., Bernal-López, M. R., & Gómez‐Huelgas, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125961 · Cited by 12
Beta‐cell function in type 2 diabetes ( T2DM ): Can it be preserved or enhanced?
Kassem, L. S., Rajpal, A., Barreiro, M. V. E., & Ismail‐Beigi, F. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13446 · Cited by 14
Cellular mechanism of diabetes remission by bariatric surgery
Ye, J., Hu, Y.-X., Wang, C., Lian, H., & Dong, Z. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.07.001 · Cited by 11
Gastric Bypass vs Diet and Cardiovascular Risk Factors
Karlsson, C., Johnson, L. K., Greasley, P. J., Retterstøl, K., Hedberg, J., Hall, M., Hawker, N., Robertsen, I., Havsol, J., Hertel, J. K., et al. (2024) · JAMA Surgery · doi:10.1001/jamasurg.2024.2162 · Cited by 11
Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies
Morissette, A., & Mulvihill, E. E. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.07.012 · Cited by 12
Metadata
- Authors
- Yoshino, M., Kayser, B. D., Yoshino, J., Stein, R. I., Reeds, D., Eagon, J. C., Eckhouse, S. R., Watrous, J. D., Jain, M., Knight, R., Schechtman, K., Patterson, B. W., & Klein, S.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-08-20
- Volume
- 383
- Issue
- 8
- Pages
- 721-732
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC7456610
- OpenAlex
- W3057164079
- Semantic Scholar
- 58b956f40f349fa8a015a5f60e342e5528184ac1
- Cited by
- 246
- References
- 47
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 28 · 2023: 41 · 2022: 59 · 2021: 57 · 2020: 17
- FWCI
- 39.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (T32HL130357)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK116917, P30DK063491, P30DK56341, R01DK101578, T32DK007296, U24DK097153)
- NIH Office of the Director (S10OD020025)
- National Institute of Environmental Health Sciences (P42ES010337, R01ES027595)
- Pershing Square Foundation
- Foundation for Barnes-Jewish Hospital
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, Roux-en-Y gastric bypass, bariatric surgery, weight loss, dietary therapy, hepatic insulin sensitivity, skeletal muscle insulin sensitivity, beta-cell function, glucose homeostasis, glucose production, insulin-stimulated glucose disposal, obesity, hyperinsulinemic-euglycemic clamp, insulin secretion
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Obesity, Prospective Studies, Remission Induction, Glucose Clamp Technique, Gastric Bypass, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
